Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Labo

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,950	304 Pages	Fatpos Global	September, 2023	FAGL18367065

Best Price Guarantee
Price	from $4,950
Length	304 Pages
Publisher	Fatpos Global
Published Date	September, 2023
SKU	FAGL18367065

Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032

Clinical Diagnostics Market Size, Share, and Analysis, By Test (Liver Panel, Lipid Panel, Renal Panel, Electrolyte Testing, Complete Blood Count, Infectious Disease Testing, Others), By Product (Reagents, Instruments, Others), By End User (Diagnostic Laboratory, Hospital Laboratory, Point-of-care Testing, Others) and Regional Forecasts, 2022-2032

PRODUCT OVERVIEW

Clinical Diagnostics Market size was USD 66.86 billion in 2021 and projected to grow from USD 75.9 billion in 2023 to USD 135.5 billion by 2032, exhibiting a CAGR of 6.6% during the forecast period.

Clinical diagnostic services give physicians a variety of instruments to aid in decision making related to best therapy required for patients with different diseases. The frequency of chronic and infectious diseases is increasing along with the implementation of automated platforms which is anticipated to boost the market growth. Clinical diagnostics denotes the process of recognising, identifying and observing disease through signs, symptoms, physical examination of a patient. They help in disease management to enhance health and well-being along with the classification of patients with diverse diseases.

MARKET HIGHLIGHTS

Clinical Diagnostics Market is expected to reach USD 135.5 billion, growing at a CAGR of 6.6% during forecast period owing to the factors like changing lifestyles of individuals with unhealthy habits, which resulted in acquiring diseases like hypertension, diabetes, and cardiovascular issues. Growing digital participation permit consumers to involve in clinical outcomes, high operational cost-cutting which is expected to boost the market growth during the forecast period. Increasing acceptance of non-invasive prenatal testing created attention for implementation of innovative nanomaterials, and point-of-care medical diagnostics which is anticipated to drive the demand for the market growth.

Clinical Diagnostics Market Segments:

Test
Liver Panel
Lipid Panel
Renal Panel
Electrolyte Testing
Complete Blood Count
Infectious Disease Testing
Others
Product
Reagents
Instruments
Others
End User
Diagnostic Laboratory
Hospital Laboratory
Point-of-care Testing
Others

MARKET DYNAMICS

Growth Drivers

Increasing Demand for Clinical Diagnostic is Expected to Boost the Market Growth

Increasing Incidence of Chronic Diseases is Expected to Boost the Growth of the Market

Restraint

Easy Availability of Molecular Diagnostics May Restrain the Growth of the Market

Key Players

BioMerieux
ARUP Laboratories
Becton, Dickinson, and Company
Abbott Laboratories
Qiagen
Bio-Reference Laboratories
Labcorp
Bioscientia Healthcare
Danaher Corporation
Quest Diagnostics Inc.
Hologic Inc.
F. Hoffmann-La Roche AG
Thermo Fisher Scientific
Sonic Healthcare Ltd
Sysmex Corporation
Siemens AG
Other Prominent Players (Company Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis)

Global Laboratory Temperature Control Units Market is further segmented by region into:

North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA

Reasons to Purchase this Report

Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
3-month post-sales analyst support.

*Please Note: The report will be delivered in 4-5 business days upon order confirmation*

1. Executive Summary: 1.1.Regional Market Share; 1.2. Business Trends; 1.3. Clinical Diagnostics Market: COVID-19 Outbreak; 1.4.Regional Trends; 1.5. Segmentation Snapshot
2. Research Methodology: 2.1. Research Objective; 2.2.Research Approach; 2.3.Data Sourcing and Methodology; 2.4. Primary Research; 2.5. Secondary Research; 2.5.1.Paid Sources; 2.5.2. Public Sources; 2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics: 3.1. Market Definition; 3.2.Clinical Diagnostics Market: COVID-19 Impact; 3.3.Key Segmentations; 3.4. Key Developments; 3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights: 4.1.Industry Segmentation; 4.2. COVID-19 overview on world economy; 4.3. Industry ecosystem Channel analysis; 4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments: 7.Market Dynamics; 7.1. Introduction; 7.2.Growth Drivers; 7.3.Market Opportunities; 7.4. Market Restraints; 7.5.Market Trends
8. Risk Analysis
9. Market Analysis: 9.1. Porters Five Forces; 9.2.PEST Analysis; 9.2.1. Political; 9.2.2.Economic; 9.2.3.Social; 9.2.4.Technological
10. Clinical Diagnostics Market: 10.1.Overview; 10.2. Historical Analysis (2016-2021); 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast; 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F; 11.1.Overview; 11.2. Key Findings; 11.3. Market Segmentation; 11.3.1.By Test; 11.3.1.1. Liver Panel; 11.3.1.1.1. By Value (USD Million) 2022-2032F; 11.3.1.1.2.Market Share (%) 2022-2032F; 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F; 11.3.1.2.Lipid Panel; 11.3.1.2.1.By Value (USD Million) 2022-2032F; 11.3.1.2.2. Market Share (%) 2022-2032F; 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.3.Renal Panel; 11.3.1.3.1.By Value (USD Million) 2022-2032F; 11.3.1.3.2. Market Share (%) 2022-2032F; 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.4.Electrolyte Testing; 11.3.1.4.1.By Value (USD Million) 2022-2032F; 11.3.1.4.2. Market Share (%) 2022-2032F; 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.5.Complete Blood Count; 11.3.1.5.1.By Value (USD Million) 2022-2032F; 11.3.1.5.2. Market Share (%) 2022-2032F; 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.6.Infectious Disease Testing; 11.3.1.6.1.By Value (USD Million) 2022-2032F; 11.3.1.6.2. Market Share (%) 2022-2032F; 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.7.Others; 11.3.1.7.1.By Value (USD Million) 2022-2032F; 11.3.1.7.2. Market Share (%) 2022-2032F; 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F; 11.3.2. By Product; 11.3.2.1.Reagents; 11.3.2.1.1.By Value (USD Million) 2022-2032F; 11.3.2.1.2. Market Share (%) 2022-2032F; 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F; 11.3.2.2. Instruments; 11.3.2.2.1. By Value (USD Million) 2022-2032F; 11.3.2.2.2.Market Share (%) 2022-2032F; 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F; 11.3.2.3. Others; 11.3.2.3.1. By Value (USD Million) 2022-2032F; 11.3.2.3.2.Market Share (%) 2022-2032F; 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3. By End User; 11.3.3.1.Diagnostic Laboratory; 11.3.3.1.1.By Value (USD Million) 2022-2032F; 11.3.3.1.2. Market Share (%) 2022-2032F; 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F; 11.3.3.2. Hospital Laboratory; 11.3.3.2.1. By Value (USD Million) 2022-2032F; 11.3.3.2.2.Market Share (%) 2022-2032F; 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3.3. Point-of-care Testing; 11.3.3.3.1. By Value (USD Million) 2022-2032F; 11.3.3.3.2.Market Share (%) 2022-2032F; 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3.4. Others; 11.3.3.4.1. By Value (USD Million) 2022-2032F; 11.3.3.4.2. Market Share (%) 2022-2032F; 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F: 12.1. Overview; 12.2. Key Findings; 12.3. Market Segmentation; 12.3.1. By Test; 12.3.2.By Product; 12.3.3.By End User; 12.4. Country; 12.4.1.United States; 12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F: 13.1. Overview; 13.2. Key Findings; 13.3. Market Segmentation; 13.3.1. By Test; 13.3.2.By Product; 13.3.3.By End User; 13.4. Country; 13.4.1.Germany; 13.4.2. United Kingdom; 13.4.3. France; 13.4.4. Italy; 13.4.5. Spain; 13.4.6. Russia; 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F: 14.1.Overview; 14.2. Key Findings; 14.3. Market Segmentation; 14.3.1. By Test; 14.3.2.By Product; 14.3.3.By End User; 14.4. Country; 14.4.1.India; 14.4.2. China; 14.4.3. South Korea; 14.4.4. Japan; 14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F: 15.1.Overview; 15.2. Key Findings; 15.3. Market Segmentation; 15.3.1. By Test; 15.3.2.By Product; 15.3.3.By End User; 15.4. Country; 15.4.1.Israel; 15.4.2. GCC; 15.4.3. North Africa; 15.4.4. South Africa; 15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F: 16.1. Overview; 16.2. Key Findings; 16.3. Market Segmentation; 16.3.1. By Test; 16.3.2.By Product; 16.3.3.By End User; 16.4. Country; 16.4.1. Mexico; 16.4.2. Brazil; 16.4.3. Rest of Latin America
17. Competitive Landscape: 17.1. Company market share, 2021; 17.2.Key player overview; 17.3. Key stakeholders
18. Company Profiles: 18.1.BioMerieux; 18.1.1.Company Overview; 18.1.2.Financial Overview; 18.1.3.Key Product; Analysis; 18.1.4.Company Assessment; 18.1.4.1.Product Portfolio; 18.1.4.2. Key Clients; 18.1.4.3. Market Share; 18.1.4.4. Recent News & Development (Last 3 Yrs.); 18.1.4.5. Executive Team; 18.2. ARUP Laboratories; 18.3. Becton, Dickinson, and Company; 18.4.Abbott Laboratories; 18.5. Qiagen; 18.6. Bio-Reference Laboratories; 18.7. Labcorp; 18.8.Bioscientia Healthcare; 18.9. Danaher Corporation; 18.10.Quest Diagnostics Inc.; 18.11.Hologic Inc.; 18.12.F. Hoffmann-La Roche AG; 18.13.Thermo Fisher Scientific; 18.14.Sonic Healthcare Ltd; 18.15.Sysmex Corporation; 18.16. Siemens AG; 18.17. Other Prominent Players
19. Appendix: 20.Consultant Recommendation
1. Executive Summary: 1.1.Regional Market Share; 1.2. Business Trends; 1.3. Clinical Diagnostics Market: COVID-19 Outbreak; 1.4.Regional Trends; 1.5. Segmentation Snapshot
2. Research Methodology: 2.1. Research Objective; 2.2.Research Approach; 2.3.Data Sourcing and Methodology; 2.4. Primary Research; 2.5. Secondary Research; 2.5.1.Paid Sources; 2.5.2. Public Sources; 2.6.Market Size Estimation and Data Triangulation
3. Market Characteristics: 3.1. Market Definition; 3.2.Clinical Diagnostics Market: COVID-19 Impact; 3.3.Key Segmentations; 3.4. Key Developments; 3.5. Allied Industry Data
4. Clinical Diagnostics Market – Industry Insights: 4.1.Industry Segmentation; 4.2. COVID-19 overview on world economy; 4.3. Industry ecosystem Channel analysis; 4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments: 7.Market Dynamics; 7.1. Introduction; 7.2.Growth Drivers; 7.3.Market Opportunities; 7.4. Market Restraints; 7.5.Market Trends
8. Risk Analysis
9. Market Analysis: 9.1. Porters Five Forces; 9.2.PEST Analysis; 9.2.1. Political; 9.2.2.Economic; 9.2.3.Social; 9.2.4.Technological
10. Clinical Diagnostics Market: 10.1.Overview; 10.2. Historical Analysis (2016-2021); 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast; 11.Clinical Diagnostics Market Size & Forecast 2022A-2032F; 11.1.Overview; 11.2. Key Findings; 11.3. Market Segmentation; 11.3.1.By Test; 11.3.1.1. Liver Panel; 11.3.1.1.1. By Value (USD Million) 2022-2032F; 11.3.1.1.2.Market Share (%) 2022-2032F; 11.3.1.1.3.Y-o-Y Growth (%) 2022-2032F; 11.3.1.2.Lipid Panel; 11.3.1.2.1.By Value (USD Million) 2022-2032F; 11.3.1.2.2. Market Share (%) 2022-2032F; 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.3.Renal Panel; 11.3.1.3.1.By Value (USD Million) 2022-2032F; 11.3.1.3.2. Market Share (%) 2022-2032F; 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.4.Electrolyte Testing; 11.3.1.4.1.By Value (USD Million) 2022-2032F; 11.3.1.4.2. Market Share (%) 2022-2032F; 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.5.Complete Blood Count; 11.3.1.5.1.By Value (USD Million) 2022-2032F; 11.3.1.5.2. Market Share (%) 2022-2032F; 11.3.1.5.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.6.Infectious Disease Testing; 11.3.1.6.1.By Value (USD Million) 2022-2032F; 11.3.1.6.2. Market Share (%) 2022-2032F; 11.3.1.6.3. Y-o-Y Growth (%) 2022-2032F; 11.3.1.7.Others; 11.3.1.7.1.By Value (USD Million) 2022-2032F; 11.3.1.7.2. Market Share (%) 2022-2032F; 11.3.1.7.3. Y-o-Y Growth (%) 2022-2032F; 11.3.2. By Product; 11.3.2.1.Reagents; 11.3.2.1.1.By Value (USD Million) 2022-2032F; 11.3.2.1.2. Market Share (%) 2022-2032F; 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F; 11.3.2.2. Instruments; 11.3.2.2.1. By Value (USD Million) 2022-2032F; 11.3.2.2.2.Market Share (%) 2022-2032F; 11.3.2.2.3.Y-o-Y Growth (%) 2022-2032F; 11.3.2.3. Others; 11.3.2.3.1. By Value (USD Million) 2022-2032F; 11.3.2.3.2.Market Share (%) 2022-2032F; 11.3.2.3.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3. By End User; 11.3.3.1.Diagnostic Laboratory; 11.3.3.1.1.By Value (USD Million) 2022-2032F; 11.3.3.1.2. Market Share (%) 2022-2032F; 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F; 11.3.3.2. Hospital Laboratory; 11.3.3.2.1. By Value (USD Million) 2022-2032F; 11.3.3.2.2.Market Share (%) 2022-2032F; 11.3.3.2.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3.3. Point-of-care Testing; 11.3.3.3.1. By Value (USD Million) 2022-2032F; 11.3.3.3.2.Market Share (%) 2022-2032F; 11.3.3.3.3.Y-o-Y Growth (%) 2022-2032F; 11.3.3.4. Others; 11.3.3.4.1. By Value (USD Million) 2022-2032F; 11.3.3.4.2. Market Share (%) 2022-2032F; 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
12. North America Clinical Diagnostics Market Size & Forecast 2022A-2032F: 12.1. Overview; 12.2. Key Findings; 12.3. Market Segmentation; 12.3.1. By Test; 12.3.2.By Product; 12.3.3.By End User; 12.4. Country; 12.4.1.United States; 12.4.2. Canada
13. Europe Clinical Diagnostics Market Size & Forecast 2022A-2032F: 13.1. Overview; 13.2. Key Findings; 13.3. Market Segmentation; 13.3.1. By Test; 13.3.2.By Product; 13.3.3.By End User; 13.4. Country; 13.4.1.Germany; 13.4.2. United Kingdom; 13.4.3. France; 13.4.4. Italy; 13.4.5. Spain; 13.4.6. Russia; 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia Clinical Diagnostics Market Size & Forecast 2022A-2032F: 14.1.Overview; 14.2. Key Findings; 14.3. Market Segmentation; 14.3.1. By Test; 14.3.2.By Product; 14.3.3.By End User; 14.4. Country; 14.4.1.India; 14.4.2. China; 14.4.3. South Korea; 14.4.4. Japan; 14.4.5. Rest of APAC
15. Middle East and Africa Clinical Diagnostics Market Size & Forecast 2022A-2032F: 15.1.Overview; 15.2. Key Findings; 15.3. Market Segmentation; 15.3.1. By Test; 15.3.2.By Product; 15.3.3.By End User; 15.4. Country; 15.4.1.Israel; 15.4.2. GCC; 15.4.3. North Africa; 15.4.4. South Africa; 15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Diagnostics Market Size & Forecast 2022A-2032F: 16.1. Overview; 16.2. Key Findings; 16.3. Market Segmentation; 16.3.1. By Test; 16.3.2.By Product; 16.3.3.By End User; 16.4. Country; 16.4.1. Mexico; 16.4.2. Brazil; 16.4.3. Rest of Latin America
17. Competitive Landscape: 17.1. Company market share, 2021; 17.2.Key player overview; 17.3. Key stakeholders
18. Company Profiles: 18.1.BioMerieux; 18.1.1.Company Overview; 18.1.2.Financial Overview; 18.1.3.Key Product; Analysis; 18.1.4.Company Assessment; 18.1.4.1.Product Portfolio; 18.1.4.2. Key Clients; 18.1.4.3. Market Share; 18.1.4.4. Recent News & Development (Last 3 Yrs.); 18.1.4.5. Executive Team; 18.2. ARUP Laboratories; 18.3. Becton, Dickinson, and Company; 18.4.Abbott Laboratories; 18.5. Qiagen; 18.6. Bio-Reference Laboratories; 18.7. Labcorp; 18.8.Bioscientia Healthcare; 18.9. Danaher Corporation; 18.10.Quest Diagnostics Inc.; 18.11.Hologic Inc.; 18.12.F. Hoffmann-La Roche AG; 18.13.Thermo Fisher Scientific; 18.14.Sonic Healthcare Ltd; 18.15.Sysmex Corporation; 18.16. Siemens AG; 18.17. Other Prominent Players
19. Appendix: 20.Consultant Recommendation